Lixte Biotechnology Holdings Inc's Company Valuation
Currency: USD Updated: 2026-06-18
Previous score
6.61
Change
0
The current valuation score of Lixte Biotechnology Holdings Inc is 6.61, ranking 314 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -6.64, which is -92.82% below the recent high of -0.48 and 0.00% above the recent low of -6.64.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.